These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17596583)

  • 1. Parental transmission of MS in a population-based Canadian cohort.
    Herrera BM; Ramagopalan SV; Orton S; Chao MJ; Yee IM; Sadovnick AD; Ebers GC
    Neurology; 2007 Sep; 69(12):1208-12. PubMed ID: 17596583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis.
    Kowalec K; Harder A; Dolovich C; Fitzgerald KC; Salter A; Lu Y; Bernstein CN; Bolton JM; Cutter G; Fisk JD; Gelernter J; Graff LA; Hägg S; Hitchon CA; Levey DF; Lublin FD; McKay KA; Patten S; Patki A; Stein MB; Tiwari HK; Wolinsky JS; Marrie RA
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1393-1404. PubMed ID: 38715244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
    Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
    Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?
    Pakpoor J; Saylor D; Izbudak I; Liu L; Mowry EM; Yousem DM
    AJNR Am J Neuroradiol; 2017 Jan; 38(1):12-17. PubMed ID: 27758773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
    Ruano L; Portaccio E; Goretti B; Niccolai C; Severo M; Patti F; Cilia S; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Trojano M; Viterbo RG; Amato MP
    Mult Scler; 2017 Aug; 23(9):1258-1267. PubMed ID: 27738090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Multiple Sclerosis.
    Howard J; Trevick S; Younger DS
    Neurol Clin; 2016 Nov; 34(4):919-939. PubMed ID: 27720001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain health: time matters in multiple sclerosis.
    Giovannoni G; Butzkueven H; Dhib-Jalbut S; Hobart J; Kobelt G; Pepper G; Sormani MP; Thalheim C; Traboulsee A; Vollmer T
    Mult Scler Relat Disord; 2016 Sep; 9 Suppl 1():S5-S48. PubMed ID: 27640924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
    Knier B; Schmidt P; Aly L; Buck D; Berthele A; Mühlau M; Zimmer C; Hemmer B; Korn T
    Brain; 2016 Nov; 139(11):2855-2863. PubMed ID: 27581073
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term evolution of multiple sclerosis disability in the treatment era.
    ; Cree BA; Gourraud PA; Oksenberg JR; Bevan C; Crabtree-Hartman E; Gelfand JM; Goodin DS; Graves J; Green AJ; Mowry E; Okuda DT; Pelletier D; von Büdingen HC; Zamvil SS; Agrawal A; Caillier S; Ciocca C; Gomez R; Kanner R; Lincoln R; Lizee A; Qualley P; Santaniello A; Suleiman L; Bucci M; Panara V; Papinutto N; Stern WA; Zhu AH; Cutter GR; Baranzini S; Henry RG; Hauser SL
    Ann Neurol; 2016 Oct; 80(4):499-510. PubMed ID: 27464262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Effects of Gadolinium-Based Contrast Agents: Changes in Practice Patterns.
    Forghani R
    Top Magn Reson Imaging; 2016 Aug; 25(4):163-9. PubMed ID: 27367314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence of disease activity in multiple sclerosis patients.
    Matta AP; Nascimento OJ; Ferreira AC; Magalhães TN; Benevides TP; Kirmse A; Dib JG; Cal H; Orsini M; Araujo LM
    Expert Rev Neurother; 2016 Nov; 16(11):1279-1284. PubMed ID: 27352830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging neuroinflammation in multiple sclerosis using TSPO-PET.
    Airas L; Rissanen E; Rinne JO
    Clin Transl Imaging; 2015; 3(6):461-473. PubMed ID: 27331049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Multiple Sclerosis Relapse.
    Berkovich RR
    Continuum (Minneap Minn); 2016 Jun; 22(3):799-814. PubMed ID: 27261683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.
    Cruz-Herranz A; Balk LJ; Oberwahrenbrock T; Saidha S; Martinez-Lapiscina EH; Lagreze WA; Schuman JS; Villoslada P; Calabresi P; Balcer L; Petzold A; Green AJ; Paul F; Brandt AU; Albrecht P;
    Neurology; 2016 Jun; 86(24):2303-9. PubMed ID: 27225223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep and Cognitive Function in Multiple Sclerosis.
    Braley TJ; Kratz AL; Kaplish N; Chervin RD
    Sleep; 2016 Aug; 39(8):1525-33. PubMed ID: 27166237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision Disturbances in Multiple Sclerosis.
    Costello F
    Semin Neurol; 2016 Apr; 36(2):185-95. PubMed ID: 27116725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
    Hagens M; van Berckel B; Barkhof F
    Curr Opin Neurol; 2016 Jun; 29(3):229-36. PubMed ID: 27058220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
    Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
    Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guide to treating gait impairment with prolonged-release fampridine (Fampyra
    Ramió-Torrentà L; Álvarez-Cermeño JC; Arroyo R; Casanova-Estruch B; Fernández O; García-Merino JA; Hernández MA; Izquierdo G; Martínez-Yélamos S; Meca J; Moral E; Olascoaga J; Prieto JM; Saiz A
    Neurologia (Engl Ed); 2018 Jun; 33(5):327-337. PubMed ID: 26873645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.
    Kappos L; De Stefano N; Freedman MS; Cree BA; Radue EW; Sprenger T; Sormani MP; Smith T; Häring DA; Piani Meier D; Tomic D
    Mult Scler; 2016 Sep; 22(10):1297-305. PubMed ID: 26585439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.